Uses and Limitations of Positron Emission Tomography in Clinical Pharmacokinetics/Dynamics (Part II) (Q36215997)

12 August 2017

1 reference

title

Uses and Limitations of Positron Emission Tomography in Clinical Pharmacokinetics/Dynamics (Part II) (English)

1 reference

10.2165/00003088-199222040-00003

Crossref

DOI

https://api.crossref.org/works/10.2165/00003088-199222040-00003

positron emission tomography

14 October 2022

main subject

1 reference

emission computed tomography

inferred from title

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1606787

14 October 2022

1 reference

10.2165/00003088-199222040-00003

https://api.crossref.org/works/10.2165/00003088-199222040-00003

14 October 2022

1 reference

L. L. Ponto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1606787

14 October 2022

J. A. Ponto

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1606787

14 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1606787

14 October 2022

publication date

1 April 1992

1 reference

Clinical Pharmacokinetics

12 August 2017

1 reference

12 August 2017

22

1 reference

12 August 2017

4

1 reference

12 August 2017

274-283

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199222040-00003

12 August 2017

0 references

cites work

Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography.

1 reference

12 December 2020

Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography

1 reference

12 December 2020

Positron tomography. A new method for in vivo brain studies of benzodiazepine, in animal and in man

1 reference

12 December 2020

Maps of receptor binding parameters in the human brain--a kinetic analysis of PET measurements.

1 reference

12 December 2020

Slowly progressive aphasia: three cases with language, memory, CT and PET data

1 reference

12 December 2020

Measurement of blood-brain hexose transport with dynamic PET: comparison of [18F]2-fluoro-2-deoxyglucose and [11C]O-methylglucose

1 reference

12 December 2020

Synthesis of ethyl 8-fluoro-5,6-dihydro5- [11C]methyl-6-oxo-4H-imidazo[1,5-a] [1,4]benzodiazepine-3-carboxylate (RO 15.1788-11C): A specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography

1 reference

12 December 2020

Analysis of three- and four-compartment models for in vivo radioligand-neuroreceptor interaction.

1 reference

12 December 2020

Nonoxidative glucose consumption during focal physiologic neural activity

1 reference

12 December 2020

In reply: elevated d2 dopamine receptors in drug-naive schizophrenics

1 reference

12 December 2020

Regional specific binding of [11C]RO 15 1788 to central type benzodiazepine receptors in human brain: quantitative evaluation by PET

1 reference

12 December 2020

Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy.

1 reference

12 December 2020

Effect of adenosine on human cerebral blood flow as determined by positron emission tomography.

1 reference

12 December 2020

Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.

1 reference

12 December 2020

L-methionine uptake by human cerebral cortex: maturation from infancy to old age.

1 reference

12 December 2020

Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography.

1 reference

12 December 2020

Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography

1 reference

12 December 2020

Measurement of local blood flow and distribution volume with short-lived isotopes: a general input technique.

1 reference

12 December 2020

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

1 reference

12 December 2020

Delineation of myocardial oxygen utilization with carbon-11-labeled acetate

1 reference

12 December 2020

Local cerebral metabolic rate for glucose during petit mal absences.

1 reference

12 December 2020

Intersubject variation in the pharmacokinetics of haloperidol and reduced haloperidol

1 reference

12 December 2020

Turnover of brain monoamine oxidase measured in vivo by positron emission tomography using L-[11C]deprenyl.

1 reference

12 December 2020

Strategies for in vivo measurement of receptor binding using positron emission tomography.

1 reference

12 December 2020

Central type benzodiazepine binding sites: a positron emission tomography study in the baboon's brain.

1 reference

12 December 2020

Persistence of Haloperidol in the Brain

1 reference

12 December 2020

1 reference

12 December 2020

Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina

1 reference

12 December 2020

Alternative approach to single-scan estimation of cerebral glucose metabolic rate using glucose analogs, with particular application to ischemia

1 reference

12 December 2020

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

1 reference

12 December 2020

Single-scan Bayes estimation of cerebral glucose metabolic rate: comparison with non-Bayes single-scan methods using FDG PET scans in stroke.

1 reference

12 December 2020

Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients

1 reference

12 December 2020

Pharmacokinetics of superselective intra-arterial and intravenous [11C]BCNU evaluated by PET.

1 reference

12 December 2020

Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis.

1 reference

12 December 2020

Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients.

1 reference

12 December 2020

Economic analysis of clinical positron emission tomography of the heart with rubidium-82

1 reference

12 December 2020

The theory and applications of the exchange of inert gas at the lungs and tissues

1 reference

12 December 2020

Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers.

1 reference

12 December 2020

Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients: a positron tomography study.

1 reference

12 December 2020

A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography

1 reference

12 December 2020

Stereoselective binding of 11C-raclopride in living human brain--a search for extrastriatal central D2-dopamine receptors by PET.

1 reference

12 December 2020

Examination of assumptions for local cerebral blood flow studies in PET.

1 reference

12 December 2020

Three-dimensional assessment of myocardial oxidative metabolism: a new approach for regional determination of PET-derived carbon-11-acetate kinetics

1 reference

12 December 2020

The early days of the indifferent gas method for measuring cerebral blood flow.

1 reference

12 December 2020

Status epilepticus induced by pentylenetetrazole modulates in vivo [11C]Ro 15-1788 binding to benzodiazepine receptors. Effects of ligands acting at the supramolecular receptor complex.

1 reference

12 December 2020

Reversibility of cardiac wall-motion abnormalities predicted by positron tomography

1 reference

12 December 2020

Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography.

1 reference

12 December 2020

Effects of acute alcohol intoxication on cerebral blood flow measured with PET

1 reference

12 December 2020

3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans

1 reference

12 December 2020

Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography

1 reference

12 December 2020

Comparative regional analysis of 2-fluorodeoxyglucose and methylglucose uptake in brain of four stroke patients. With special reference to the regional estimation of the lumped constant.

1 reference

12 December 2020

Temporoparietal cortex in aphasia. Evidence from positron emission tomography.

1 reference

12 December 2020

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

12 December 2020

PET, CT, and MRI in the evaluation of neuropsychiatric disorders: current applications

1 reference

12 December 2020

Stereoselectivity in pharmacokinetics: a general theory

1 reference

12 December 2020

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.

1 reference

12 December 2020

Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis

1 reference

12 December 2020

Regression model for predicting dissociations of regional cerebral glucose metabolism in individuals at risk for Huntington's disease

1 reference

12 December 2020

THE NITROUS OXIDE METHOD FOR THE QUANTITATIVE DETERMINATION OF CEREBRAL BLOOD FLOW IN MAN: THEORY, PROCEDURE AND NORMAL VALUES.

1 reference

12 December 2020

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

1 reference

12 December 2020

Noninvasive determination of local cerebral metabolic rate of glucose in man.

1 reference

12 December 2020

Quantification of Neuroreceptors in the living human brain. II. Inhibition studies of receptor density and affinity.

1 reference

12 December 2020

[13N]cisplatin PET to assess pharmacokinetics of intra-arterial versus intravenous chemotherapy for malignant brain tumors.

1 reference

12 December 2020

Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum

1 reference

12 December 2020

Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography

1 reference

12 December 2020

Positron emission tomography. Prospects for clinical utility

1 reference

12 December 2020

Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization

1 reference

12 December 2020

Sensitivity of Cerebral Glucose Metabolism to Age, Gender, Brain Volume, Brain Atrophy, and Cerebrovascular Risk Factors

1 reference

12 December 2020

Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia

1 reference

12 December 2020

Positron emission tomography: clinical status in the United States in 1987. ACNP/SNM Task Force on Clinical PET

1 reference

12 December 2020

Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET.

1 reference

12 December 2020

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

1 reference

12 December 2020

Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography.

1 reference

12 December 2020

Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia

1 reference

12 December 2020

The applications of PET in clinical oncology

1 reference

12 December 2020

[18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain.

1 reference

12 December 2020

Cerebral glucose metabolism as a function of age in man: influence of the rate constants in the fluorodeoxyglucose method.

1 reference

12 December 2020

Planning and financing a PET center

1 reference

12 December 2020

Mapping cocaine binding sites in human and baboon brain in vivo.

1 reference

12 December 2020

PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site.

1 reference

12 December 2020

Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands

1 reference

12 December 2020

Duration of occupancy of opiate receptors by naltrexone

1 reference

12 December 2020

A study of the single compartment tracer kinetic model for the measurement of local cerebral blood flow using 15O-water and positron emission tomography

1 reference

12 December 2020

F-18 deoxyglucose and stress N-13 ammonia positron emission tomography in anterior wall healed myocardial infarction.

1 reference

12 December 2020

Serum haloperidol concentration and clinical response in schizophrenia

1 reference

12 December 2020

Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET.

1 reference

12 December 2020

Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose.

1 reference

12 December 2020

Mapping muscarinic receptors in human and baboon brain using [N-11C-methyl]-benztropine.

1 reference

12 December 2020

Cerebral glucose hypermetabolism in Friedreich's ataxia detected with positron emission tomography.

1 reference

12 December 2020

Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism

1 reference

12 December 2020

Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1-11C]acetate and dynamic positron emission tomography

1 reference

12 December 2020

Cerebral metabolic relationships for selected brain regions in healthy adults.

1 reference

12 December 2020

Quantification of human caudate d2 dopamine receptor density with positron emission tomography: a review of the model

1 reference

12 December 2020

Imaging histamine H1 receptors in the living human brain with carbon-11-pyrilamine

1 reference

12 December 2020

Quantitative evaluation of L-[methyl-C-11] methionine uptake in tumor using positron emission tomography

1 reference

12 December 2020

Quantitative measurement of local cerebral blood flow in humans by positron computed tomography and 15O-water

1 reference

12 December 2020

Naltrexone: disposition, metabolism, and effects after acute and chronic dosing

1 reference

12 December 2020

Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.

1 reference

12 December 2020

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.

1 reference

12 December 2020

Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies

1 reference

12 December 2020

Non-Q wave versus Q wave myocardial infarction: regional myocardial metabolism and blood flow assessed by positron emission tomography.

1 reference

12 December 2020

Striatal function in normal aging: implications for Parkinson's disease.

1 reference

12 December 2020

Acute effects of ethanol on regional brain glucose metabolism and transport

1 reference

12 December 2020

Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans

1 reference

12 December 2020

Mapping brain neuroleptic receptors in the live baboon.

1 reference

12 December 2020

The kinetics and displacement of [11C]flunitrazepam in the brain of the living baboon

1 reference

12 December 2020

Alternative formula for glucose utilization using labeled deoxyglucose

1 reference

12 December 2020

Comparison of CT, MR, and PET in Alzheimer's dementia and normal aging

1 reference

12 December 2020

Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction

1 reference

12 December 2020

PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride.

1 reference

12 December 2020

Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose

1 reference

12 December 2020

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

1 reference

12 December 2020

Elevated D2 dopamine receptors in drug-naïve schizophrenics.

1 reference

12 December 2020

Where have we got to with neuroreceptor mapping of the human brain?

1 reference

12 December 2020

A relationship between metabolism in frontal lobes and cerebellum in normal subjects studied with PET

1 reference

12 December 2020

Positron emission tomography (PET) in the study of dopamine receptors in the primate brain: evaluation of a kinetic model using 11C-N-methyl-spiperone

1 reference

12 December 2020

A simplified in vivo autoradiographic strategy for the determination of regional cerebral blood flow by positron emission tomography: theoretical considerations and validation studies in the rat.

1 reference

12 December 2020

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

1 reference

12 December 2020

Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation.

1 reference

12 December 2020

Assessment of myocardial oxidative metabolic reserve with positron emission tomography and carbon-11 acetate

1 reference

12 December 2020

Radiolabeled acetate as a tracer of myocardial tricarboxylic acid cycle flux

1 reference

12 December 2020

Cost analyses of positron emission tomography for clinical use.

1 reference

12 December 2020

Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches

1 reference

12 December 2020

Imaging of [11C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography

1 reference

12 December 2020

No D2 receptor increase in PET study of schizophrenia

1 reference

12 December 2020

Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlu from dynamic [18F] fluorodeoxyglucose/PET data

1 reference

12 December 2020

Prediction of survival in glioma patients by means of positron emission tomography

1 reference

12 December 2020

Reproducibility of cerebral glucose metabolic measurements in resting human subjects.

1 reference

12 December 2020

10.2165/00003088-199222040-00003

Identifiers

DOI

0 references

Dimensions Publication ID

0 references

1 reference